FDA starts review of Pfizer, Lilly’s non-opioid painkiller

FDA starts review of Pfizer, Lilly’s non-opioid painkiller

Submitted by admin on March 3, 2020 - 10:49am
Source: 
Pharmaforum
News Tags: 
Pfizer
Eli Lilly
tanezumab
painkillers
FDA
non-opioid pain treatments
Headline: 
FDA starts review of Pfizer, Lilly’s non-opioid painkiller
snippet: 

After years in development, the FDA has started its review of Pfizer and Eli Lilly’s new painkiller tanezumab, one of two remaining drugs in the ill-fated nerve growth factor (NGF) inhibitor class.

Do Not Allow Advertisers to Use My Personal information